Koyfin Home > Directory > Health Care > Acceleron Pharma > Cash from Investing Activities

Acceleron Pharma Cash from Investing Activities Chart (XLRN)

Acceleron Pharma annual/quarterly Cash from Investing Activities from 2012 to 2020.
  • Acceleron Pharma Cash from Investing Activities for the quarter ending June 06, 2020 was $30m a -26.84% decrease of -8m year over year
  • Acceleron Pharma Cash from Investing Activities for the last 12 months ending June 06, 2020 was $227m a 141.05% increase of 320m year over year
  • Acceleron Pharma Annual Cash from Investing Activities for 2019 was $-71m a 272.43% decrease of -194m from 2018
  • Acceleron Pharma Annual Cash from Investing Activities for 2018 was $123m a 152.36% increase of 187m from 2017
  • Acceleron Pharma Annual Cash from Investing Activities for 2017 was $-64m a -69.04% increase of 44m from 2016
Other Cash Flow Metrics:
  • Acceleron Pharma Cash Flow from Operations for the quarter ending December 12, 2018 was $-29m a 19.28% decrease of -6m year over year
  • Acceleron Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-41m a 62.43% decrease of -26m year over year
  • Acceleron Pharma Total Revenue for the quarter ending September 09, 2018 was $3m a -13.72% decrease of 0m year over year
View Chart On Koyfin

Quarterly XLRN Cash from Investing Activities Data

06/2020$30m
03/2020$77m
12/2019$82m
09/2019$38m
06/2019$-38m
03/2019$-153m
12/2018$60m
09/2018$45m
06/2018$30m
03/2018$-12m

Annual XLRN Cash from Investing Activities Data

2019$-71m
2018$123m
2017$-64m
2016$-109m
2015$-109m
2014$-1m
2013$0m
2012$0m
2011$0m